STENOCARE reports H1 2026 results with Q2 sales rising 33%
Q2 net sales reached DKK 4 million with positive EBITDA for the fifth consecutive quarter. The CannGros integration is complete as France preparations continue.
Latest STENOCARE News & Updates
See the latest news and media coverage for STENOCARE. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical cannabis pharmaceutical company
stenocare.com- Headquarters
- Kirke Værløse, Denmark
- Founded year
- 2017
- Company type
- Public company
- Number of employees
- 5–10
- Industry
- Pharmaceuticals
Last updated
Latest news about STENOCARE
In short: Stenocare reached its fifth consecutive EBITDA-positive quarter in Q2 2026, with sales up 33% as it expanded into France and Germany.
Company announcements
Stenocare completes integration of CannGros ApS
The corporate merger is finalized and process optimisations implemented to reduce cost and lead time.
Stenocare delivers strong Q1 results
Sales rose 15% to 3 million DKK with positive EBITDA and operating cash flow. Integration of CannGros strengthens market position. Expects growth and break-even in 2026.
Stenocare publishes its Annual Report 2025
The report highlights record year, strong sales growth, EBITDA improvement, and CannGros acquisition for 2026 break-even.
Media coverage
Stenocare A/S: STENOCARE reports first-half results with continued momentum: Q2 sales rise 33% over Q1 with fifth consecutive EBITDA-positive quarter
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2026 - 30.06.2026. The report...
Stenocare A/S: Interim report first quarter 2026
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENOSTENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2026 - 31.03.2026. The report, which...
STENOCARE A/S publishes Annual Report 2025
STENOCARE A/S published the annual report for 2025, which shows three quarters with positive EBITDA and a record net revenue of 7.0 million DKK, which is a...
Stenocare reached EBITDA breakeven in Q4
Stenocare A/S announces its results for 2025. The year's net revenue rose to 7,021 t.kr. from 2,232 t.kr. in 2024. The year's EBITDA was -1,742 t.kr., but...
Never miss news about STENOCARE
Track STENOCARE and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.